SCHEMBL1672841

SCHEMBL1672841

COc1ccc(-c2c(Br)c(C)c(C#N)n2-c2c(C)noc2C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PTGS2 P35354 1/20 0.39
MAPT P10636 2/20 0.36
BRD4 O60885 4/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NTRK1 P04629 1/20 0.34
PIM1 P11309 1/20 0.34
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
CREBBP Q92793 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BRD2 P25440 1/20 0.33
BRD3 Q15059 1/20 0.33
THRB P10828 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1670583 0.88 MAOA (0.38) MAOAMAOBPTGS2MAPTBRD4
SCHEMBL12986874 0.84 CREBBP (0.39) PTGS2MAPTBRD4RAB9ANPSR1
SCHEMBL12800447 0.82 PTGS2 (0.41) PTGS2MAPTBRD4NPC1RAB9A
SCHEMBL1670344 0.78 PTGS2 (0.39) MAOAMAOBPTGS2MAPTBRD4
SCHEMBL1670731 0.74 BRD4 (0.34) BRD4
SCHEMBL1670708 0.72 PTGS2 (0.43) PTGS2MAPTBRD4NPC1RAB9A
SCHEMBL12800962 0.72 PTGS2 (0.40) PTGS2MAPTBRD4NPC1RAB9A
SCHEMBL1670920 0.70 PTGS2 (0.47) PTGS2BRD4NPSR1CREBBPBRD2
SCHEMBL12986067 0.70 ALDH1A1 (0.35) MAPTBRD4SMN1; SMN2CREBBPALDH1A1
SCHEMBL12800442 0.69 BRD4 (0.33) MAPTBRD4NPC1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011042477-A1 SUBSTITUTED PYRROLES AND IMIDAZOLES AS ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-04-14 WO disclosed